Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The newly established company is dedicated to helping bring cannabis-based drugs to market.
May 22, 2024
By: Charlie Sternberg
Cannovation Clinical Research Partners, a Cannabis-Based Clinical Research Organization for Drug and Product Development, has officially launched. Founded by pharmaceutical and biotech executive Lisa Rich-Milan, alongside cannabis industry leader Michael Zaccaria, Cannovation aims to “spearhead a revolution in medicine” through the introduction of cannabinoid-based therapeutics. The newly established company is dedicated to collaborating with pharmaceutical and biotechnology companies, universities, Centers of Excellence, and DEA researchers to bring cannabis-based drugs to market, covering pre-clinical, clinical trials, and U.S. commercialization phases. Cannovation specializes in partnering with organizations developing innovative prescription and non-prescription drugs or products utilizing cannabinoids. It offers a comprehensive suite of services, ranging from turnkey solutions for success and strategic market entry, to navigating the intricate regulatory frameworks in the U.S., all tailored to meet each client’s unique needs. Rich-Milan stated, “We are thrilled to embark on this transformative journey leveraging the power of cannabinoids. At Cannovation, we are committed to providing unparalleled support to companies seeking to harness the potential of cannabinoid-based therapeutics. We unite pharma, biotechnology, and Cannabis at the forefront of innovation, seamlessly connecting the dots for our clients.” Zaccaria added, “Together with Lisa and our team, we are dedicated to fostering innovation and excellence in both the pharmaceutical and cannabis sectors,” said Zaccaria. “Cannovation Clinical Research Partners, LLC serves as a vital bridge between these industries, facilitating the development and commercialization of groundbreaking cannabinoid drugs.” Cannovation takes a holistic approach to assist businesses throughout the entire product lifecycle, encompassing product development (pre-clinical and clinical), commercialization, and launch phases. Leveraging its network of expertise and industry connections, Cannovation Clinical Research Partners, LLC equips clients with the tools and support to successfully navigate the intricate landscape of cannabinoid therapeutics.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
